SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-19-000025
Filing Date
2019-11-14
Accepted
2019-11-14 16:12:03
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20190930x10q.htm 10-Q 1225830
2 EXHIBIT 10.1 exhbit101-trinityschedule4.htm EX-10.1 23843
3 EXHIBIT 10.5 q32019exhibit105.htm EX-10.5 25116
4 EXHIBIT 31.1 q3exhibit311.htm EX-31.1 10052
5 EXHIBIT 31.2 q3exhibit312.htm EX-31.2 10777
6 EXHIBIT 32.1 q3exhibit321.htm EX-32.1 13127
  Complete submission text file 0001587221-19-000025.txt   5991876

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT zsan-20190930.xml EX-101.INS 1245841
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20190930.xsd EX-101.SCH 49535
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20190930_cal.xml EX-101.CAL 89265
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20190930_def.xml EX-101.DEF 164496
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20190930_lab.xml EX-101.LAB 593605
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20190930_pre.xml EX-101.PRE 325470
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 191220257
SIC: 2834 Pharmaceutical Preparations